Nyxoah (XBRU:NYXH) Accounts Payable & Accrued Expense : €11.73 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Accounts Payable & Accrued Expense?

Nyxoah's quarterly accounts payable & accrued expense increased from Sep. 2023 (€11.19 Mil) to Dec. 2023 (€12.35 Mil) but then declined from Dec. 2023 (€12.35 Mil) to Mar. 2024 (€11.73 Mil).

Nyxoah's annual accounts payable & accrued expense increased from Dec. 2021 (€9.29 Mil) to Dec. 2022 (€13.18 Mil) but then declined from Dec. 2022 (€13.18 Mil) to Dec. 2023 (€12.35 Mil).

Nyxoah Accounts Payable & Accrued Expense Historical Data

The historical data trend for Nyxoah's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Accounts Payable & Accrued Expense Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.42

4.94

9.29

13.18

12.35

Nyxoah Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															12.41	12.86	11.19	12.35	11.73

Nyxoah Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Nyxoah (XBRU:NYXH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (XBRU:NYXH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

NYXH:USA 5YI:Germany

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.